4//SEC Filing
KALOBIOS PHARMACEUTICALS INC 4
Accession 0001181431-14-003370
CIK 0001293310operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 6:19 PM ET
Size
9.3 KB
Accession
0001181431-14-003370
Insider Transaction Report
Form 4
Yarranton Geoffrey Thomas
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2014-01-19+75,000→ 75,000 totalExercise: $5.41Exp: 2024-01-19→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option shares will vest and become exercisable ratably over 48 months of continuous service after January 1, 2014.
Issuer
KALOBIOS PHARMACEUTICALS INC
CIK 0001293310
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001293310
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 6:19 PM ET
- Size
- 9.3 KB